Retinitis Pigmentosa (RP) Completed Phase 2 Trials for Omega-3 fatty acids (DB11133)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00100230DHA and X-Linked Retinitis PigmentosaPrevention